Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model.
about
Dissimilar Fitness Associated with Resistance to Fluoroquinolones Influences Clonal Dynamics of Various Multiresistant BacteriaAntimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile InfectionFaecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection.Antibiotic discovery in the twenty-first century: current trends and future perspectives.Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringensModels for the study of Clostridium difficile infection.Surface layer proteins from virulent Clostridium difficile ribotypes exhibit signatures of positive selection with consequences for innate immune responsePotential of lactoferrin to prevent antibiotic-induced Clostridium difficile infectionMolecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro.Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile.Epidemiology, diagnosis and treatment of Clostridium difficile infection.The detrimental impact of extracellular bacterial proteases on wound healing.Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut model.In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection.Tolevamer is not efficacious in the neutralization of cytotoxin in a human gut model of Clostridium difficile infection.Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model.Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system.
P2860
Q26741585-28A43B2B-D846-4D5C-A6A4-ED75F518484FQ28084026-6E01B94A-CCAA-44B3-9943-D3B036DEE097Q33782277-13270DA4-15D0-4DE3-BB12-17FC11835651Q34121033-DE949355-F67C-421C-A728-9EAFE10A0A76Q34604406-3C8A1C16-3685-43A9-B52A-D5269EFB05CCQ36019356-5275112D-8ADA-4470-9F54-C502794F2619Q36320846-0FCAE74D-2601-4561-918A-118A957CBD92Q36684188-D8DF2211-86DA-4305-B13F-4CB3ABE74BA3Q37204206-996D3E3C-6745-4349-87F9-7725CEFC9BA5Q37543222-2B0E453B-DBE8-4487-B8FE-6FCC24625867Q38068605-0E5FC186-13AD-4D81-967B-217A6D60DB94Q39458904-0907AB20-01B9-48E5-9B5B-7E0D41931D8CQ41272713-C5A5985F-0FFF-4431-BA68-D37F8E6E6E44Q42244128-2B94DE7D-8740-4C83-9DEB-1DEBE2D18527Q43128393-84524FB6-0E2C-4B48-BF28-A02CEAFF8657Q43817719-94ACA9FE-2A7A-443E-A555-E8552EAA5D2DQ45573898-67F51C7B-4DA9-4A89-9A26-9A07574335EC
P2860
Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Effects of exposure of Clostri ...... inolones in a human gut model.
@en
Effects of exposure of Clostri ...... inolones in a human gut model.
@en-gb
type
label
Effects of exposure of Clostri ...... inolones in a human gut model.
@en
Effects of exposure of Clostri ...... inolones in a human gut model.
@en-gb
prefLabel
Effects of exposure of Clostri ...... inolones in a human gut model.
@en
Effects of exposure of Clostri ...... inolones in a human gut model.
@en-gb
P2093
P2860
P356
P1476
Effects of exposure of Clostri ...... inolones in a human gut model.
@en
P2093
Katie Saxton
Rachael O'Connor
Simon D Baines
P2860
P304
P356
10.1128/AAC.00306-08
P407
P577
2008-08-18T00:00:00Z